Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

SpectraCell Signs National Contract With Aetna

SpectraCell Laboratories has signed an agreement with Aetna Health, to become a contracted in-network provider. The contract provides coverage of SpectraCell's micronutrient testing, and other advanced tests by Aetna.

Aetna acknowledge SpectraCell’s micronutrient testing as a valuable piece of the healthcare puzzle, changing the current paradigm of disease-care to true wellness-care and prevention.

SpectraCell’s micronutrient testing provides an innovative analysis of a patient’s nutritional status. Unlike traditional serum, hair and urine tests, SpectraCell’s tests measure how an individual’s white blood cells function in specific nutritional environments.

Consequently, the test results take into account individual variations in metabolism, absorption rates, age, genetics, prescription drug usage and other factors. Over 30 vitamins, minerals, amino acids and antioxidants can be evaluated.

SpectraCell’s lipoprotein particle profile is the advanced lipoprotein testing available. Unlike traditional cholesterol tests, SpectraCell’s Lipoprotein Particle Profile (LPP) directly measures both the size (density) and number of several classes of lipoprotein particles, providing an accurate assessment of cardiovascular risk.

Rusty Preece, VP and chief financial officer of SpectraCell, said: “Much of the cutting edge technology in health care is emerging in the field of diagnostics. SpectraCell’s micronutrient testing, originally developed at the University of Texas, is a prime example of advanced clinical tools.

“Insurers see the value in identification and targeted correction of patients’ specific vitamin and mineral deficiencies, which have a major impact on underlying disease processes.”